Fundamental Valuation Report Theravance Biopharma(TBPH:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.95 (USD) 04/09/2021 Weighted Valuation$24.51 (USD) Overall RatingUndervalued by 17.0% Valuation Models Comparables: $32.74 (USD) Multiples: $28.64 (USD) …

Theravance Biopharma (TBPH:NAS) Fundamental Valuation Report Read more »

Read More